MIRA Pharmaceuticals, Inc.MIRANASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank40
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-5.33M
↓ 42% vs avg
Percentile
P40
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-3.75M
Historical baseline
PeriodValueYoY Change
TTM$-5.33M+4.1%
2024$-5.56M-22.7%
2023$-4.53M+19.1%
2022$-5.60M-307.3%
2021$-1.38M-1924.0%
2020$-67993.00-